Theralase Technologies Stock Analysis

Theralase OTC Stock Analysis Notes

The company recorded a loss per share of 0.02. Theralase Technologies had not issued any dividends in recent years. Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds and their associated drug formulations to treat cancer, bacteria, and viruses in Canada, the United States, and internationally. Theralase Technologies Inc. was founded in 1994 and is based in Toronto, Canada. Theralase Technologi operates under Medical Devices classification in the United States and is traded on OTC Exchange.The quote for Theralase Technologies is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about Theralase Technologies contact Roger DumoulinWhite at 416 699 5273 or learn more at https://www.theralase.com.

Theralase Technologies Investment Alerts

Theralase Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 61.59 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Theralase Technologies's market, we take the total number of its shares issued and multiply it by Theralase Technologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 2nd of February, Theralase Technologies has the Risk Adjusted Performance of 0.0316, semi deviation of 4.63, and Coefficient Of Variation of 3629.37. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Theralase Technologies, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Theralase Technologies, which can be compared to its competition. Please validate Theralase Technologies variance, as well as the relationship between the maximum drawdown and semi variance to decide if Theralase Technologies is priced more or less accurately, providing market reflects its prevalent price of 0.19 per share. As Theralase Technologies appears to be a penny stock we also recommend to double-check its total risk alpha numbers.

Theralase Technologies Price Movement Analysis

Theralase Technologies Outstanding Bonds

Theralase Technologies Predictive Daily Indicators

Theralase Technologies Forecast Models

Theralase Technologies' time-series forecasting models are one of many Theralase Technologies' otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Theralase Technologies' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Theralase Technologies prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Theralase shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Theralase Technologies. By using and applying Theralase OTC Stock analysis, traders can create a robust methodology for identifying Theralase entry and exit points for their positions.

When running Theralase Technologies' price analysis, check to measure Theralase Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theralase Technologies is operating at the current time. Most of Theralase Technologies' value examination focuses on studying past and present price action to predict the probability of Theralase Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theralase Technologies' price. Additionally, you may evaluate how the addition of Theralase Technologies to your portfolios can decrease your overall portfolio volatility.